Latest / Why We Do What We Do / Mini: Designer Genes
Transcript
- 0:03Speaker 1: You're listening to Why we do what we do? Welcome
- 0:15Speaker 1: to Why we do what we do Many I am
- 0:18Speaker 1: your host Abraham and I'm your oh Shane. We are
- 0:21Speaker 1: a psychology podcast. We talk about the things that humans
- 0:24Speaker 1: and non human animals do and then things we do
- 0:27Speaker 1: to them before they're even borns that they do things
- 0:30Speaker 1: we want them to do differently.
- 0:33Speaker 2: That was so succinct, Thank you well.
- 0:37Speaker 1: It needed to be, because this is a mini minis
- 0:40Speaker 1: we release on Monday's are short, bite sized episodes. We
- 0:43Speaker 1: try and keep them under fifteen minutes. Want to get
- 0:45Speaker 1: into this topic and then wrap it up as quickly
- 0:47Speaker 1: as we can so that we have enough information to
- 0:50Speaker 1: have left you with something useful, but not so much
- 0:52Speaker 1: that you had to dedicate your whole afternoon to listening
- 0:55Speaker 1: to it or morning whenever you check this out. We
- 0:57Speaker 1: release these in the morning, so hopefully morning all right.
- 1:00Speaker 1: If you'd like to support us, leave us a rating
- 1:01Speaker 1: and review, like, subscribe, tell a friend, join us on Patreon.
- 1:04Speaker 1: I'll talk more about that at the end of this discussion.
- 1:07Speaker 1: If you're joining us for the first time, welcome, Hope
- 1:09Speaker 1: you enjoyed with you here in this podcast episode. And
- 1:11Speaker 1: if you're a returning person, then welcome back. We're so
- 1:13Speaker 1: glad that you continue to visit us. Either way, we
- 1:16Speaker 1: are doing a mini which means it's short, which means
- 1:18Speaker 1: I need to stop rambling and pre rambling and get
- 1:21Speaker 1: into our topic du jour. Are you ready?
- 1:23Speaker 2: Yeah, yeah, yeah, let's do some post rambling.
- 1:25Speaker 1: Let's do some post rambling. With the invention and development
- 1:29Speaker 1: of several new technologies that have allowed for precise gene editing,
- 1:34Speaker 1: we as a species are like on the precipice of
- 1:38Speaker 1: possibly being able to directly manipulate the genes of human beings. Technically,
- 1:42Speaker 1: we've actually already crossed that threshold. But I mean, you know,
- 1:46Speaker 1: and this is not even beyond selectively breeding people, which
- 1:49Speaker 1: people have also done. This is actually about going in
- 1:53Speaker 1: and changing the genetics of an existing embryo to have
- 1:56Speaker 1: certain features and characteristics, which someone has also done, which
- 2:00Speaker 1: I didn't plan to talk about in this episode, so
- 2:01Speaker 1: I'm not going to bring it up again unless it
- 2:03Speaker 1: comes up. But that is a that is where we're at,
- 2:05Speaker 1: as we're like on the precipice of this being a
- 2:07Speaker 1: widespread practice.
- 2:09Speaker 3: Yeah, why would we even do this? We're actually gonna
- 2:12Speaker 3: talk about some of those arguments for and against genetically
- 2:15Speaker 3: altering humans. Now, this is delicate water to tread. Yeah, okay,
- 2:21Speaker 3: so I think there is a slippery slope. I don't
- 2:24Speaker 3: know if you talk about this in this episode. Do
- 2:25Speaker 3: you talk about eugenics at all a bit?
- 2:27Speaker 1: Yes, that's sort of another Yeah, yeah, beautiful. We will.
- 2:30Speaker 3: We will talk about that because I think it is
- 2:32Speaker 3: a slippery slope as we get into things. So just
- 2:34Speaker 3: we'll just we want to put that disclaimer out there
- 2:37Speaker 3: that this is one of those ones where you go,
- 2:39Speaker 3: I don't know, yeah, this could go in a dark
- 2:42Speaker 3: direction or not. Yes, I mean, we're going to discuss
- 2:45Speaker 3: the things that are said, but we'll also try and
- 2:50Speaker 3: make the case fairly clear. I want to start by
- 2:53Speaker 3: making sure we're all clear we're not talking about altering
- 2:56Speaker 3: the genes of someone who's already born right now. The
- 2:59Speaker 3: discussion around editing genes has to do with editing the
- 3:02Speaker 3: genetics code of a human embryo so that the future
- 3:07Speaker 3: child born of the embryo then grows up with the
- 3:09Speaker 3: alterations that form the basis and the structure of their
- 3:13Speaker 3: genetic and biological development following their birth. Sure, right, Like,
- 3:18Speaker 3: is that clear.
- 3:20Speaker 2: Yeah, yeah, yeah, yeah, yah.
- 3:21Speaker 3: So I think that's a good point that kind of
- 3:23Speaker 3: like maybe start even getting into arguments for this. Right So,
- 3:26Speaker 3: when we are talking about doing this gene editing thing
- 3:29Speaker 3: or this this geninary process that's coming up, we're talking
- 3:31Speaker 3: about maybe some of the arguments for it are things
- 3:33Speaker 3: like preventing genetic diseases or bolstering strength and ability of
- 3:37Speaker 3: said human after they're born. So one example is Huntingdon's disease.
- 3:42Speaker 3: So Huntingdon's disease is a fatal neurodegenerative genetic disease with
- 3:46Speaker 3: an onset in the thirties or forties that results in irritability,
- 3:50Speaker 3: difficult decision making, difficulty learning new things, extreme weight loss,
- 3:53Speaker 3: muscle loss, in voluntary movements, difficulty swallowing or moving, and death.
- 3:58Speaker 3: It has no treatment right now, no cure, and no prevention.
- 4:02Speaker 3: So the idea is that you could possibly use something
- 4:05Speaker 3: like gene editing to remove the gene that would be
- 4:08Speaker 3: responsible for Huntingdon's disease developing in somebody who is in
- 4:12Speaker 3: their thirties and forties.
- 4:14Speaker 1: Yeah see, I mean you'd edit the gene of an
- 4:16Speaker 1: embryo and then that way, if the person had the
- 4:18Speaker 1: capability of developing this disease. You will have taken that
- 4:22Speaker 1: capability away and they will live a life without ever
- 4:25Speaker 1: having developed this disease, because it is a horrible, horrible disease.
- 4:30Speaker 2: Right.
- 4:30Speaker 1: Cystic Fibrosis is a chronic genetic disease in which a
- 4:33Speaker 1: thick mucus clogs the lungs, pancreas, and other organs and
- 4:37Speaker 1: makes it extremely difficult to breathe. And I've been in
- 4:41Speaker 1: class like workshop things where this the experience of breathing
- 4:45Speaker 1: with cystic fibrosis is like being able to only breathe
- 4:47Speaker 1: through a straw. It is like you might think that
- 4:50Speaker 1: doesn't sound so bad, but try it. It is incredibly uncomfortable,
- 4:53Speaker 1: like it sucks. And most people with cystic fibrosis live
- 4:57Speaker 1: only into their forties or fifties, which is actually a
- 5:00Speaker 1: tremendous improvement from what it was. There are treatments now
- 5:03Speaker 1: that do help mitigate this, and there have been some
- 5:06Speaker 1: versions of treatments for a long time, although a lot
- 5:08Speaker 1: of them were fairly limited in scope and how much
- 5:10Speaker 1: they could actually do. But the new and emerging treatments
- 5:13Speaker 1: and the things that really do prolonged life are extremely expensive,
- 5:17Speaker 1: costing one hundred thousand to one hundred and thirty thousand
- 5:20Speaker 1: dollars every year to help manage this. Like, this is
- 5:25Speaker 1: someone who's in middle classes, entire annual salary, right like
- 5:30Speaker 1: being spent on this. This is an extremely expensive disease
- 5:33Speaker 1: that in extremely painful, extremely uncomfortable, and fatal if not treated.
- 5:38Speaker 2: Right.
- 5:39Speaker 3: Another example that is you can make the argument for
- 5:41Speaker 3: this would be muscular dystrophee. It's a genetic disease that
- 5:44Speaker 3: results in a lack of muscle control, muscle rigidity, tripping
- 5:47Speaker 3: following difficulty getting up and waddling or toe walking when upright.
- 5:51Speaker 3: This can further lead to difficulty breathing and heart failure.
- 5:54Speaker 3: It is one of the most expensive diseases to treat,
- 5:56Speaker 3: including new Toshane genetic treatments that cost up to three
- 5:59Speaker 3: point two million dollars for a single treatment.
- 6:04Speaker 1: That is, that's a lot. That is a lot of money.
- 6:07Speaker 2: Yeah, that's that's too much money for a treatment. But
- 6:09Speaker 2: that's that's where we're at right now.
- 6:11Speaker 1: We do not get nearly that much for ads. All right,
- 6:20Speaker 1: we're back. So we're talking about some of the various
- 6:22Speaker 1: genetic diseases that exists that could possibly be treated with
- 6:26Speaker 1: something like genetic engineering. Some other arguments that are in
- 6:29Speaker 1: favor of the the people who argue for continue to
- 6:34Speaker 1: advance science around genetic editing and engineering are that as
- 6:38Speaker 1: we continue to advance this, it will lead to the
- 6:40Speaker 1: kinds of regulations needed to proceed carefully and ethically, as
- 6:44Speaker 1: opposed to placing a universal moratorium on researching genetic editing,
- 6:48Speaker 1: which would not allow us to further develop systems and
- 6:52Speaker 1: regulations to facilitate this kind of work should it emerge
- 6:55Speaker 1: when it does emerge. So they're they're kind of making
- 6:58Speaker 1: the case like, we will get a lot better at
- 7:01Speaker 1: this if we're allowed to do it, but we won't
- 7:03Speaker 1: get better at this if we're not allowed to do it.
- 7:05Speaker 3: Right, right, And perhaps super genetically enhanced babies will be
- 7:09Speaker 3: the next great leaders that will change the world. We'd
- 7:12Speaker 3: be investing in the super geniuses of the future to
- 7:15Speaker 3: help engineer policies to shape a better society. So that
- 7:17Speaker 3: means that we wouldn't have MAGA anymore. They would just
- 7:20Speaker 3: fall by the wayside. But there is something to be
- 7:22Speaker 3: said about the idea of that component, right, like the
- 7:26Speaker 3: maybe greater cognitive capacities, maybe like there's lots of things
- 7:30Speaker 3: that could happen that people. And again this is not
- 7:32Speaker 3: us making this argument. This is what people will say
- 7:33Speaker 3: is like, people could be smarter, they could be more insightful,
- 7:36Speaker 3: they could be more empathetic, they could do all those
- 7:38Speaker 3: things if we're able to edit genes in certain ways.
- 7:41Speaker 1: Yeah, peak human potential is sort of whether you're going yes, now,
- 7:45Speaker 1: it does lead us very importantly to the arguments against this.
- 7:48Speaker 1: All of that might have sounded fairly convincing, and I
- 7:50Speaker 1: would not blame you if you were convinced by those arguments.
- 7:53Speaker 1: Those genetic diseases are terrible. The possibility to maximize human
- 7:56Speaker 1: capability sounds like a good idea. The arguments for this
- 8:00Speaker 1: or a cautionary tale. We're thinking about like designer children.
- 8:03Speaker 1: There is going to be an emphasis on fair skin.
- 8:06Speaker 1: There just will be like that. That is just the
- 8:07Speaker 1: thing that will happen. Not to say that there will
- 8:09Speaker 1: not be any other type of skin color in genetically
- 8:11Speaker 1: engineered babies, but the preference predominantly across the world has
- 8:16Speaker 1: been a preference toward farer skin, and so that is
- 8:19Speaker 1: going to be where the emphasis, not exclusion, but the
- 8:21Speaker 1: emphasis will be placed. And this will further widen the
- 8:24Speaker 1: inequality gap. And this leads to another argument that people
- 8:27Speaker 1: against this have raised is who is to say what
- 8:30Speaker 1: is something that needs to be quote unquote fixed in
- 8:34Speaker 1: someone's choice? Like who gets to make that choice? Because
- 8:38Speaker 1: depending on the person or the people put in charge
- 8:40Speaker 1: of that, they might have a very specific and clear
- 8:42Speaker 1: agenda about what they think makes sense. And therein lies
- 8:46Speaker 1: kind of the problem with eugenics broadly speaking, is classifying
- 8:50Speaker 1: something that is not a problem as a problem that
- 8:53Speaker 1: needs to be fixed.
- 8:54Speaker 3: Yeah, I mean that is the crux of ableism. Yeah,
- 8:57Speaker 3: at its core, really it is.
- 9:00Speaker 2: Yeah, I mean.
- 9:01Speaker 3: Truly, Like I mean, like autistic folks and members of
- 9:03Speaker 3: the autism community talk about this constantly, and we talked
- 9:05Speaker 3: about this on the Asperger's episode. Yeah, because this is
- 9:08Speaker 3: one thing that comes up often, is like, if you
- 9:10Speaker 3: can edit genes, then you can eliminate something like autism.
- 9:14Speaker 3: And the argument is like, well, what's so bad about autism?
- 9:17Speaker 3: And that's where some of the ablest arguments come in, right, Yeah,
- 9:20Speaker 3: That's why I said it's a slippery slope because when
- 9:21Speaker 3: you get int the like disability, you're like, oh okay,
- 9:24Speaker 3: Like who's to say what is a disability and like
- 9:26Speaker 3: what's good and what's bad and what needs to be fixed,
- 9:28Speaker 3: and that's part of why this becomes a slippery slope.
- 9:31Speaker 3: And the other side of this too is like this
- 9:33Speaker 3: would definitely only be available to the rich and the
- 9:36Speaker 3: lucky and leave most people behind. So this wouldn't even
- 9:38Speaker 3: be accessible to most people.
- 9:40Speaker 1: Yeah, definitely at first, it's possibly become more widespread, but
- 9:43Speaker 1: it's extremely unlikely. Like the likely outcome is that rich
- 9:46Speaker 1: people get to make it so that they don't have
- 9:49Speaker 1: to worry about healthcare because they're genetically altered in such
- 9:52Speaker 1: a way that they don't get sick, they don't get diseases,
- 9:54Speaker 1: they don't get injuries, whatever the problem is, right, Like,
- 9:56Speaker 1: their lives are even already easier than they were to
- 9:59Speaker 1: begin with. So that's that's definitely a consideration there. And
- 10:02Speaker 1: then another important consideration here is like there are things
- 10:05Speaker 1: that we just don't know about how genetic changes affect
- 10:08Speaker 1: the entire sequence of other interacting genes, Like what are
- 10:12Speaker 1: the externalities of making an edit to a genetic sequence,
- 10:16Speaker 1: what are the cascading effects? We don't know those things.
- 10:19Speaker 1: And I think people might argue, well, we aren't going
- 10:21Speaker 1: to know those unless we do the research. But I'm
- 10:23Speaker 1: like that's a pretty high cost, Like these could really
- 10:25Speaker 1: result in things somebody's life. Yeah, this is someone's life
- 10:28Speaker 1: we're messing with here that we don't actually know what
- 10:30Speaker 1: the what the considerations are about these that we could
- 10:35Speaker 1: just sort of will anely say like, well, let's just
- 10:36Speaker 1: go ahead and change it and see what happens. Like
- 10:38Speaker 1: we can do evolution better than evolution, can I don't
- 10:41Speaker 1: think so. I am pessimistic that that is true.
- 10:45Speaker 2: Yeah, yeah, exactly. There are just other considerations here too,
- 10:48Speaker 2: like you know, what is considered good as far as
- 10:51Speaker 2: good genes versus bad genes.
- 10:52Speaker 3: Like there' that's a subjective and often weaponized question, right,
- 10:56Speaker 3: I mean that is that's part of the problem. So
- 10:58Speaker 3: half a century ago, being gay would have been a
- 11:00Speaker 3: serious consideration for selectively omitting some gene that is responsible
- 11:05Speaker 3: I mean if that's the case, right, like responsible for
- 11:08Speaker 3: somebody's orientation. This is something that would have been targeted
- 11:12Speaker 3: under gene therapy.
- 11:13Speaker 1: Yeah, yeah, they would. People would be looking for, all right,
- 11:15Speaker 1: what are the genetic markers associated with homosexuality? Let's root
- 11:18Speaker 1: that out. And I'm like, I don't we don't we
- 11:20Speaker 1: should not be getting rid of people who do not
- 11:23Speaker 1: follow a heteronormative like preference or lifestyle. That is insane
- 11:28Speaker 1: and a terrible, terrible idea. And again, we don't know
- 11:31Speaker 1: what other effects that a given genetic mutation may have.
- 11:34Speaker 1: Like let's say someone who has Tasac syndrome, also because
- 11:39Speaker 1: of that genetic manipulation that change in their genes, they
- 11:42Speaker 1: have that disease tastes act, but as part of the
- 11:45Speaker 1: cascading effects of that, they also maybe are immune to
- 11:48Speaker 1: developing any kind of addiction. We would never know, right, Like,
- 11:53Speaker 1: those are things where it's like we just don't know
- 11:55Speaker 1: what other kind of benefits actually come from some of
- 11:57Speaker 1: these mutations. What if someone would taste could digest poison
- 12:01Speaker 1: without suffering harmful effects because their genes just happen to
- 12:04Speaker 1: have a code. And like we never experimented with that.
- 12:06Speaker 1: We weren't going around feeding people poison to see which
- 12:08Speaker 1: people naturally had immunity built up to it. But it
- 12:10Speaker 1: just so happened that this person who had this thing
- 12:13Speaker 1: also could digest poison. And when they had kids, their
- 12:16Speaker 1: kids had that same gene and they passed that on
- 12:18Speaker 1: and it spread and became more ubiquitous with throughout and
- 12:20Speaker 1: so this whole idea of like breeding out certain things
- 12:23Speaker 1: because they have traits, we just don't know what we're
- 12:25Speaker 1: selecting out right. And like this whole eugenics thing, it
- 12:29Speaker 1: presumes that we know what is a good gene, and
- 12:32Speaker 1: we don't.
- 12:33Speaker 2: We don't know what it is, and it's possible we
- 12:35Speaker 2: never will.
- 12:36Speaker 1: Yeah, I think we won't, because like what seems like
- 12:40Speaker 1: good to us is an evaluation based on some archetype
- 12:43Speaker 1: that's like, here's a thing we aspire to be that
- 12:46Speaker 1: is ultimately and I'm like, our aspirations do not suggest survival, fitness,
- 12:53Speaker 1: or like social benefit or anything like. These are not things.
- 12:56Speaker 1: And so I worry that what we do is we
- 12:59Speaker 1: get so hyper focused on a single issue that we
- 13:01Speaker 1: forget the broader context of what could be implied by this.
- 13:05Speaker 1: And like I hear something like Huntington's disease, and then
- 13:07Speaker 1: like maybe there is a case may made that there
- 13:09Speaker 1: are some genetic diseases we think like this, like this
- 13:11Speaker 1: one doesn't even have an onset until you're in your
- 13:13Speaker 1: thirties or forties, and then all it does is kill
- 13:15Speaker 1: you rapidly. Right, maybe there's a case that we made there,
- 13:18Speaker 1: But again we don't know if there may have actually
- 13:20Speaker 1: been some other benefits that came with that genetic mutation,
- 13:23Speaker 1: Like maybe up until that point, the person had the
- 13:25Speaker 1: most beautiful singing voice you've ever heard, or they were
- 13:27Speaker 1: the most talented engineer on the planet, and then all
- 13:30Speaker 1: of a sudden they developed this disease. Like we look
- 13:32Speaker 1: at let's take for example, Stephen Hawking who developed ALS,
- 13:36Speaker 1: who like maybe the gene that made ALS possible in
- 13:39Speaker 1: him was also responsible for being like a super genius
- 13:42Speaker 1: at math and quantum physicis R And it's like, all
- 13:44Speaker 1: you had to do was be exposed to the right environment,
- 13:46Speaker 1: and you are going to be extremely good polymth and
- 13:50Speaker 1: he was. He happened to be that we don't know.
- 13:52Speaker 1: That's the thing is like we could try and root
- 13:53Speaker 1: these things out, but we might be sacrificing something that's
- 13:56Speaker 1: really important that will benefit all of us right down
- 13:59Speaker 1: the road, Like and it is that whole idea of
- 14:02Speaker 1: eugenics that it's like we could selectively breed towards some ideal.
- 14:05Speaker 1: I'm like, there is no faking ideal, Like there is
- 14:07Speaker 1: no perfect human. And just as you said, it really
- 14:10Speaker 1: opens the door for ableism. It's like, let's get rid
- 14:12Speaker 1: of deafness. I'm like, there's the deaf community, I think
- 14:15Speaker 1: is a very happy, proud community that does not feel
- 14:17Speaker 1: like the fact that they are not hearing people has
- 14:20Speaker 1: an adverse effect on their lives. We shouldn't be taken
- 14:22Speaker 1: that away from people. Are people who are born with
- 14:24Speaker 1: like low or no vision, same thing. Like, I don't know,
- 14:28Speaker 1: it just feels like we're treating people's differences as being
- 14:32Speaker 1: bad and we just don't like there's not there's not
- 14:36Speaker 1: a reason to think that that that's bad.
- 14:39Speaker 3: Right, And and also like on the other side of that,
- 14:41Speaker 3: like let's look at people who have no genetic disease
- 14:43Speaker 3: as far as we know, but they are easily the
- 14:46Speaker 3: worst people on the planet.
- 14:47Speaker 2: Donald Trump, Elon Musk, RFK Junior, RFK Junior.
- 14:51Speaker 3: And you know, we're having these conversations and kind of
- 14:53Speaker 3: going like is that the standard?
- 14:54Speaker 2: That would be a terrible standard to aspire to if
- 14:57Speaker 2: that's the case.
- 14:58Speaker 3: So, like, you know, genetic disease that not necessarily is
- 15:02Speaker 3: not predicated on whether somebody is good or bad.
- 15:04Speaker 2: That's a different conversation.
- 15:05Speaker 3: And I think, like you said, like there is like
- 15:07Speaker 3: a certain standard that is societally normed that becomes its
- 15:12Speaker 3: own problem in this conversation.
- 15:15Speaker 1: Yeah, so with genetic editing, what we're doing essentially is
- 15:18Speaker 1: narrowing genetic diversity. And I think that these arguments, I
- 15:21Speaker 1: think are pretty strong against narrowing genetic diversity. And just
- 15:24Speaker 1: as you said, the worst people in the world don't
- 15:26Speaker 1: seem to have any genetic diseases than they exist. So
- 15:29Speaker 1: if we're't accomplished more of that, like we have one
- 15:33Speaker 1: more Donald Trump than we need as a species, arguably
- 15:36Speaker 1: we have two more since he has a son named
- 15:38Speaker 1: Donald Trump. Yeah, so man, we definitely have like five
- 15:42Speaker 1: more RFK juniors than we will ever need as a species.
- 15:45Speaker 1: They are absolutely to say the superfluous is putting it nicely. Yeah,
- 15:49Speaker 1: So where we stand on this, I feel like it's obvious.
- 15:51Speaker 1: I think that we just cannot responsibly move forward with
- 15:54Speaker 1: genetic editing without like a enormous amount of consideration and
- 15:59Speaker 1: screwtany I would be very concerned about us editing genes,
- 16:04Speaker 1: and you know, we can maybe, like I said, the
- 16:06Speaker 1: argument against removing some of these gene diseases is extremely compelling.
- 16:10Speaker 1: These are horrible experiences that are very painful that people
- 16:14Speaker 1: have to go through that makes their lives very difficult,
- 16:16Speaker 1: and maybe whatever we sacrifice to remove that is worth it.
- 16:19Speaker 1: Maybe it is, I don't know, but like I just
- 16:21Speaker 1: think that if we ever dip our toes into the
- 16:24Speaker 1: sand of engineering, eye color, skin color, height, weight, intelligence,
- 16:29Speaker 1: I'm like, that is a boundary I think we should
- 16:30Speaker 1: never ever try and cross.
- 16:32Speaker 2: Yeah, agreed, one hundred percent.
- 16:34Speaker 1: Okay, great. If you have disagreeing thoughts with us, you
- 16:36Speaker 1: should reach out and tell us. You can email us directly,
- 16:38Speaker 1: infowwdwwdpodcast dot com, or on the social media platforms. Than
- 16:43Speaker 1: we do look forward to hearing from you. I think
- 16:44Speaker 1: there's more nuance in this conversation. I think that we
- 16:46Speaker 1: only barely scratch the surface, and that was a risk
- 16:48Speaker 1: that we ran by choosing to do this as a
- 16:50Speaker 1: mini my fault, But hopefully we got enough nuance into
- 16:53Speaker 1: the conversation to at least have you be thinking about
- 16:55Speaker 1: this in a particular way, in a new way, a
- 16:57Speaker 1: different way, a more refreshed way. I don't know.
- 17:00Speaker 3: Yeah, it's a big conversation. So we're just kind of
- 17:02Speaker 3: we're just we're dipping our toes.
- 17:04Speaker 1: Yeah, but anyway, we would like to hear from you.
- 17:06Speaker 1: If you'd like to support us, join us on Patreon.
- 17:08Speaker 1: I'll read your name at the end of our full
- 17:09Speaker 1: length episodes if you do, and it'll also help us
- 17:11Speaker 1: be a podcast. So you can also leave us a
- 17:13Speaker 1: rating and review, like subscribe and tell a friend grab
- 17:15Speaker 1: the phone subscribe for them. Thank you to my team
- 17:18Speaker 1: of people who make this podcast happen. Because we're running along.
- 17:21Speaker 1: I'm not going to even read that list, but thank you. You
- 17:22Speaker 1: know who you are. I appreciate you. Is there anything
- 17:24Speaker 1: that I forgot or you'd like to add before we
- 17:26Speaker 1: wrap up?
- 17:26Speaker 2: No, I think that covers it.
- 17:27Speaker 1: Thank you all for listening.
- 17:28Speaker 2: This is Abraham and this is Shane.
- 17:30Speaker 1: Why We Do what We Do? Mini is out.
- 17:32Speaker 2: Bye. You've been listening to Why We Do What We Do.
- 17:36Speaker 2: You can learn more about this and other episodes by
- 17:39Speaker 2: going to wwd wwdpodcast dot com.
- 17:43Speaker 3: Thanks for listening, and we hope you have an awesome day.